Regulation And Legal
SEBI Confirms Interim Order Halting Par Drugs Slump Sale
SEBI confirms interim order halting Par Drugs' slump sale to a promoter entity, citing undervaluation and disclosure lapses.
Independent valuation ordered after SEBI found the proposed sale undervalue
